STICHTING MLC FOUNDATION

Their core work

MLC Foundation is a Netherlands-based organization specializing in health data infrastructure and digital health research, particularly for clinical studies and patient monitoring. They contribute to large-scale European health consortia by supporting data management, digital endpoint development, and remote clinical trial platforms. Their work spans cardiovascular disease analytics, wearable sensor integration, and exposome research — consistently focused on turning patient-generated health data into actionable clinical insights.

What they specialise in

How they've shifted over time

MLC Foundation's early H2020 work (2017–2018) centered on cardiovascular disease — heart failure, atrial fibrillation, and preterm birth outcomes — using big data approaches within traditional clinical research frameworks. From 2019 onward, the focus shifted decisively toward digital health infrastructure: remote clinical trials, wearable sensors, digital endpoints, and cloud-based platforms (IaaS/PaaS) with FAIR data principles. This trajectory shows a clear move from disease-specific data analysis toward building the digital infrastructure that enables decentralized, sensor-driven health research across multiple conditions.

MLC Foundation is moving toward becoming a digital health platform provider — organizations needing expertise in FAIR data commons, wearable integration, or decentralized trial infrastructure should consider them for future consortia.

How they like to work

MLC Foundation operates exclusively as a consortium participant, never as coordinator, which suggests they contribute specialized capabilities rather than project leadership. With 127 unique partners across 20 countries in just 5 projects, they work in very large consortia (averaging 25+ partners per project), typical of major IMI/RIA health initiatives. This means they are experienced at integrating into complex multi-partner structures and delivering defined work packages within large collaborative frameworks.

With 127 unique consortium partners across 20 countries from only 5 projects, MLC Foundation has an unusually broad European network concentrated in large-scale health research initiatives. Their partnerships span academic hospitals, pharma companies, and technology providers across most of Western and Northern Europe.

What sets them apart

MLC Foundation sits at the intersection of health data management and digital trial infrastructure — a niche that few NGOs occupy. While universities and hospitals bring clinical expertise and pharma brings drug pipelines, MLC provides the connective tissue: platforms for collecting, storing, and sharing health data across distributed research sites. For consortium builders, they offer a non-commercial, foundation-based partner for sensitive health data tasks — useful when data governance and trust matter more than commercial IP.

Highlights from their portfolio

• HEAP
  Largest funding (EUR 241K) and most technically ambitious — combines AI, wearable sensors, and multi-omics into a single exposome assessment platform with cloud infrastructure.
• IDEA-FAST
  Long-running project (2019–2026) focused on defining digital endpoints for neurodegenerative and inflammatory diseases — a regulatory frontier in clinical research.
• Trials@Home
  Center of Excellence for remote decentralized clinical trials — a model that became critically important post-COVID and represents a structural shift in how clinical research is conducted.